SFO faces criticism for closing Rolls-Royce, GSK cases

/img/field/image/rollsroycehome

The U.K. Serious Fraud Office closed two long-running bribery and corruption cases against Rolls-Royce and GlaxoSmithKline—a decision that casts further doubt around the effectiveness of the SFO’s investigatory powers and makes companies question the purpose of entering a deferred prosecution agreement at all.

lock iconTHIS IS MEMBERS-ONLY CONTENT. To continue reading, choose one of the options below.